Abstract
Among the clinical spectrum of neurological diseases, migraine is often associated with cerebro-vasculopathy. Impairment of neuroimmune mediators in the central nervous system has been recognized in the pathophysiology of migraine-related stroke. Although genetic correlation was found in patients with migraine-related stroke, the epidemiology of this disease indicates a need in biomarker searching discovery and validation. In this view, small molecule, called microRNAs (miRNAs), able to regulate immune and neuronal processes has been reported in patients with migraine and ischemic stroke and unambiguous miRNAs related to these diseases could be established as new molecular indicator of precocity for clinical and/or pharmacological intervention. Therefore, further exploration of this area is necessary, as greater understanding of these biomarkers could reveal the common mechanisms involved in the pathophysiology of migraine in patients with cerebral infarct.
Keywords: Cerebral infarct, cerebrovascular diseases, microRNA, migraine, neurological diseases, pathophysiology.
Graphical Abstract
MicroRNA
Title:microRNAs-based Predictor Factor in Patients with Migraine-ischemic Stroke
Volume: 6 Issue: 1
Author(s): Luca Gallelli, Antonio Siniscalchi*, Marco Carotenuto, Maria C. Caroleo, Erika Cione and Vincenzo Guidetti
Affiliation:
- Department of Neurology, Annunziata Hospital Via F. Migliori, 1; 87100 Cosenza,Italy
Keywords: Cerebral infarct, cerebrovascular diseases, microRNA, migraine, neurological diseases, pathophysiology.
Abstract: Among the clinical spectrum of neurological diseases, migraine is often associated with cerebro-vasculopathy. Impairment of neuroimmune mediators in the central nervous system has been recognized in the pathophysiology of migraine-related stroke. Although genetic correlation was found in patients with migraine-related stroke, the epidemiology of this disease indicates a need in biomarker searching discovery and validation. In this view, small molecule, called microRNAs (miRNAs), able to regulate immune and neuronal processes has been reported in patients with migraine and ischemic stroke and unambiguous miRNAs related to these diseases could be established as new molecular indicator of precocity for clinical and/or pharmacological intervention. Therefore, further exploration of this area is necessary, as greater understanding of these biomarkers could reveal the common mechanisms involved in the pathophysiology of migraine in patients with cerebral infarct.
Export Options
About this article
Cite this article as:
Gallelli Luca, Siniscalchi Antonio*, Carotenuto Marco, Caroleo C. Maria, Cione Erika and Guidetti Vincenzo, microRNAs-based Predictor Factor in Patients with Migraine-ischemic Stroke, MicroRNA 2017; 6 (1) . https://dx.doi.org/10.2174/2211536606666170104130101
DOI https://dx.doi.org/10.2174/2211536606666170104130101 |
Print ISSN 2211-5366 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5374 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New and Emerging Antiresorptive Treatments in Osteoporosis
Current Drug Safety In silico T-cell and B-cell Epitope Based Vaccine Design Against Alphavirus Strain of Chikungunya
Infectious Disorders - Drug Targets RNA Sensors as a Mechanism of Innate Immune Evasion among SARSCoV2, HIV and Nipah Viruses
Current Protein & Peptide Science Immune Therapy of Multiple Sclerosis - Future Strategies
Current Pharmaceutical Design Elucidation of Pathophysiology and Treatment of Neuropathic Pain
Central Nervous System Agents in Medicinal Chemistry Current Concepts in the Understanding of Pain in the Rheumatic Diseases
Current Rheumatology Reviews Study on Maternal and Neonatal Outcome of Women Undergoing Caesarean Section using NICE Classification in a Tertiary Care Hospital in Rural Area of Central India - An Observational Prospective Study
Current Women`s Health Reviews Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes
Current Neuropharmacology Carbon Monoxide - Toxicity of Low-Dose Application
Current Pharmaceutical Biotechnology Chronotherapeutic Drug Delivery Systems - An Approach to Circadian Rhythms Diseases
Current Drug Delivery Validation of Two High-Performance Liquid Chromatographic Methods for the Analysis of Nadolol and Propranolol Hydrochloride Following In Vitro Transdermal Diffusion Studies
Current Pharmaceutical Analysis Analysis of TLC-Bioautography and TLC-Spot Visualization of <i>Atropa accuminata</i> and <i>Atropa belladonna</i> Extracts as Antioxidant and Antibacterial Agents Against Human Pathogenic Bacteria
Current Pharmaceutical Analysis Central Nervous System Manifestations in Systemic Lupus Erythematosus
Current Rheumatology Reviews Pharmacological Management of Psychosis in Parkinson Disease: A Review
Current Drug Therapy A Very Rare Cerebral Complication of Chemotherapy in a Young Girl: A Difficult Diagnosis
Current Drug Safety Allergy and Inflammation: An Immunological and Therapeutic Approach
Recent Patents on Inflammation & Allergy Drug Discovery Development, Pre-clinical Investigation and Histopathological Evaluation of Metronidazole Loaded Topical Formulation for Treatment of Skin Inflammatory Disorders
Drug Delivery Letters Cardio-Hepatic Metabolic Derangements and Valproic Acid
Current Clinical Pharmacology Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option
Current Topics in Medicinal Chemistry Current Pharmacological Approaches to Prevent and Treat Post- Menopausal Osteoporosis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)